The Cutting Edge of Medical Technology Content, Community & Collaboration
Duke University Genome Center Lands $20M DARPA Grant
Colleagues,
As reported in Genome Web News ... Duke University will use a $19.5 million grant from the Defense Advanced Research Projects Agency (DARPA) to design a portable molecular diagnostic device to detect upper respiratory viruses before the host shows symptoms.
The Duke Institute for Genome Sciences and Policy (IGSP) plans to use the DARPA funds to work with collaborators at the University of Wisconsin, the University of Virginia, and the National Center for Genome Resources ...
... Duke plans to base the research on gene expression changes found in the first phase of the study which have been linked to the presence of rhinovirus, influenza A, and respiratory synctial virus. Scientists at Duke’s Pratt School of Engineering have designed a prototype of a device that can "read" the genomic signatures of these infections ....
Read on at: http://www.genomeweb.com//node/924226?emc=el&m=498529&l=3&a...
ENJOY!
CC
As reported in Genome Web News ... Duke University will use a $19.5 million grant from the Defense Advanced Research Projects Agency (DARPA) to design a portable molecular diagnostic device to detect upper respiratory viruses before the host shows symptoms.
The Duke Institute for Genome Sciences and Policy (IGSP) plans to use the DARPA funds to work with collaborators at the University of Wisconsin, the University of Virginia, and the National Center for Genome Resources ...
... Duke plans to base the research on gene expression changes found in the first phase of the study which have been linked to the presence of rhinovirus, influenza A, and respiratory synctial virus. Scientists at Duke’s Pratt School of Engineering have designed a prototype of a device that can "read" the genomic signatures of these infections ....
Read on at: http://www.genomeweb.com//node/924226?emc=el&m=498529&l=3&a...
ENJOY!
CC
Views: 7
MedTechIQ VideoLibrary
Upcoming Events
© 2024 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
